|
Report Date : |
15.10.2012 |
IDENTIFICATION DETAILS
|
Name : |
ARKRAY GLOBAL BUSINESS INC |
|
|
|
|
Registered Office : |
Arkray Global Business
KK (Overseas trading division of Arkray Inc) |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.10.2008 |
|
|
|
|
Date of Incorporation : |
July
2001 |
|
|
|
|
Com. Reg. No.: |
1300-01-023753
(Kyoto-Nakagyoku) |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Manufacturer, export of diabetes-related clinical
equipment & supplies |
|
|
|
|
No. of Employees : |
326 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
japan - ECONOMIC OVERVIEW
In the years following World War II, government-industry cooperation, a
strong work ethic, mastery of high technology, and a comparatively small
defense allocation (1% of GDP) helped Japan develop a technologically advanced
economy. Two notable characteristics of the post-war economy were the close
interlocking structures of manufacturers, suppliers, and distributors, known as
keiretsu, and the guarantee of lifetime employment for a substantial portion of
the urban labor force. Both features are now eroding under the dual pressures
of global competition and domestic demographic change. Japan's industrial
sector is heavily dependent on imported raw materials and fuels. A tiny
agricultural sector is highly subsidized and protected, with crop yields among
the highest in the world. Usually self-sufficient in rice, Japan imports about
60% of its food on a caloric basis. Japan maintains one of the world's largest
fishing fleets and accounts for nearly 15% of the global catch. For three decades,
overall real economic growth had been spectacular - a 10% average in the 1960s,
a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed
markedly in the 1990s, averaging just 1.7%, largely because of the after
effects of inefficient investment and an asset price bubble in the late 1980s
that required a protracted period of time for firms to reduce excess debt,
capital, and labor. Measured on a purchasing power parity (PPP) basis that
adjusts for price differences, Japan in 2011 stood as the fourth-largest
economy in the world after second-place China, which surpassed Japan in 2001,
and third-place India, which edged out Japan in 2011. A sharp downturn in
business investment and global demand for Japan's exports in late 2008 pushed
Japan further into recession. Government stimulus spending helped the economy
recover in late 2009 and 2010, but the economy contracted again in 2011 as the
massive 9.0 magnitude earthquake in March disrupted manufacturing. Electricity
supplies remain tight because Japan has temporarily shut down almost all of its
nuclear power plants after the Fukushima Daiichi nuclear reactors were crippled
by the earthquake and resulting tsunami. Estimates of the direct costs of the
damage - rebuilding homes, factories, and infrastructure - range from $235
billion to $310 billion, and GDP declined almost 0.5% in 2011. Prime Minister
Yoshihiko NODA has proposed opening the agricultural and services sectors to
greater foreign competition and boosting exports through membership in the
US-led Trans-Pacific Partnership trade talks and by pursuing free-trade
agreements with the EU and others, but debate continues on restructuring the
economy and reining in Japan's huge government debt, which exceeds 200% of GDP.
Persistent deflation, reliance on exports to drive growth, and an aging and
shrinking population are other major long-term challenges for the economy.
|
Source : CIA |
ARKRAY GLOBAL BUSINESS INC
Arkray Global
Business KK (Overseas trading division of Arkray Inc)
Kyoto Miyuki Bldg 10F, 689 Karasumadori Shijo-Noboru Nakagyoku Kyoto
604-8153 JAPAN
Tel:
050-5527-9306 Fax: 075-662-8973
*.. The is its Laboratory at: 57 Nishi-Aketacho Higashi Kujo Minamiku
Kyoto 601-8045, as given
URL: http://www.arkray.co.jp
E-Mail address: info@arkray.co.jp
Mfg,
export of diabetes-related clinical equipment & supplies
Nationwide
(Tot 23)
Europe,
Australia, USA, China & Korea (--Sales Offices)
Shiga
(2)
(Overseas):
China, USA
SHIGEKI
YAMADA, PRES
Kosuke
Nakanishi, dir
Takeshi
Matsuda, dir
Yen
Amount: In million Yen, unless
otherwise stated
FINANCES FAIR A/SALES Yen 37,420 M*
PAYMENTS No
Complaints CAPITAL Yen 99 M*
TREND STEADY WORTH Yen 30,904 M*
STARTED 1963 EMPLOYES 326
*.. All figures are of the
parent, Arkray Inc as of Oct/2007 fiscal term, as the subject does not release financials
as they are consolidated by the parent.
EXPORTER OF DIABETES-RELATED CLINICAL EQUIPMENT, WHOLLY oWNED BY ARKRAY INC.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY
BUSINESS ENGAGEMENTS.
The subject company was established on the overseas trading division
separated from Arkray Inc, mfg of diabetes-related clinical instruments, at the
caption address. This is an overseas
trading division of the parent with management and staff members fully
integrated with the parent, Arkray Inc.
Specializes in exporting the goods of the parent to over 80 countries
worldwide. Sales offices are in Europe,
USA, Australia, China and Korea.
(Affiliates):
Domestic: Arkray Marketing Inc (Domestic marketing division);
Arkray Global Business Inc (International marketing division);
Arkray Infinity Inc, Arkray Factory Inc (--Mfg divisions);
Arkray Digital Laboratory Inc (PC software development);
Arkray Optron Inc (Mfg of optical goods)
Overseas: Arkray Global Inc Seoul Sales Office;
Arkray Europe BV; Arkray America Inc; Color Trading Spz;
Arkray Marketing Shanghai Inc,
Arkray Factory USA Inc; Arkray Factory Shanghai Inc (--Mfg)
Financials are not disclosed as they are consolidated by the parent, Arkray
Inc, which financials are only partially disclosed. Financials are only disclosed until Oct/2007
fiscal term and not ever since.
The sales volume for Oct/2007 fiscal term amounted to Yen 37420 million,
a 33% down from Yen 54,300 million in the previous term. The net profit was posted at Yen 782 million,
compared with Yen 160 million a year ago.
The financial situation is considered FAIR and good for ORDINARY
business engagements.
Date Registered: Jul 2001
Regd No.: 1300-01-023753 (Kyoto-Nakagyoku)
Legal Status:
Limited Company (Kabushiki Kaisha)
Authorized:
800 shares
Issued: 200 shares
Sum: Yen 10
million
Major shareholders (%):
Arkray Inc*(100)
*.. Mfr of diabetes-related clinical testing equipment, at the caption
address, founded 1963, capital Yen 99 million, sales Yen 37,420 million, net
profit Yen 782 million, employees 200,
pres Takeshi Masuda;
Financials as attached (See SUPPLEMENTS).
Nothing detrimental is known as to the commercial morality of
executives.
Activities: Exports diabetes-related clinical equipment
& supplies, reagents, functional foods
as overseas trading division of Arkray Inc to over 80 countries
worldwide (--100%).
(Handling items):
Automatic Glycohemoglobin Analyzer, Fully Automated Urine Analyzer,
Versatile Urine Analysis System, Compact Urine Analyzer, Urine test strips, Dry
Clinical Chemistry Analyzer, Automated analyzer for clinical chemistry,
Electrolyte Analyzer with Ion-Selective Electrodes, Blood Ammonia Meter, Blood
glucose test meter, Lancet device for blood collection, Osmotic Pressure,
Simplified Blood Lactate Test Meter,
(Principal
overseas clients):
Bayer Corporation (USA); A Menarini Diagnostic (Italy); Tamro
Corporation (Finland); Axon Lab AG (Switz); Heska Corporation (USA); IRIS
(USA), Bayer Corp, A Menarini, Tamro Corp, other
Clients: [Hospitals,
laboratories, medical institutions] Exports to USA, Germany, Italy, Korea,
China, other.
No. of accounts: Unavailable
Domestic areas of activities: Nationwide
Suppliers: [Mfr] Supplied
wholly from the parent, Arkray Inc.
Payment record: No Complaints
Location: Business area in
Kyoto. Office premises at the caption address
are owned and maintained satisfactorily.
Bank References:
Bank
of Kyoto (Inari)
MUFG
(Kyoto-Chuo)
Relations:
Satisfactory
(In Million Yen)
Consolidated Financials of the parent,
Arkray Inc.
|
|
|
31/10/2008 |
31/10/2007 |
31/10/2006 |
31/10/2005 |
|
Annual
Sales |
|
38,000 |
37,420 |
55,530 |
5,400 |
|
Recur.
Profit |
|
|
1,663 |
|
|
|
Net
Profit |
|
800 |
782 |
260 |
222 |
|
Total
Assets |
|
|
N/A |
N/A |
N/A |
|
Net
Worth |
|
|
36,800 |
36,018 |
35,758 |
|
Capital,
Paid-Up |
|
|
99 |
99 |
99 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
1.55 |
-32.61 |
928.33 |
-89.43 |
|
|
Current Ratio |
|
|
.. |
.. |
.. |
|
N.Worth Ratio |
|
.. |
.. |
.. |
|
|
N.Profit/Sales |
2.11 |
2.09 |
0.47 |
4.11 |
|
Note:
Financials are only partially disclosed.
No financials are disclosed since Oct.2008 fiscal term
Forecast
(or estimated) for the 31/10/2008 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.70 |
|
UK Pound |
1 |
Rs.84.51 |
|
Euro |
1 |
Rs.68.16 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.